Vitamin D and androgen receptor-targeted therapy may help treat TNBC

[News]

A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy.

More... (http://www.news-medical.net/news/20160524/Vitamin-D-and-androgen-receptor-targeted-therapy-may-help-treat-TNBC.aspx)